Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
NovaRx Corporation
The primary objective of this study is to increase the overall survival of the study subjects by providing expanded access to Lucanix. Overall survival and progression-free survivals will be compared with historical controls. The secondary objectives of this study are: * Evaluate the best overall tumor response. * Evaluate progression-free survival (PFS). * Evaluate treatment toxicity.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted